Global Pyrotinib Market Growth 2025-2031

December 2025 | 75 pages | ID: G8F0B8853CAEN
LP Information

Abstracts

The global Pyrotinib market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Pyrotinib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Pyrotinib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Pyrotinib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Pyrotinib players cover Hengrui Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Pyrotinib Industry Forecast” looks at past sales and reviews total world Pyrotinib sales in 2024, providing a comprehensive analysis by region and market sector of projected Pyrotinib sales for 2025 through 2031. With Pyrotinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pyrotinib industry.

This Insight Report provides a comprehensive analysis of the global Pyrotinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pyrotinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pyrotinib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pyrotinib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pyrotinib.

This report presents a comprehensive overview, market shares, and growth opportunities of Pyrotinib market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 160mg Tables
• 80mg Tables

Segmentation by Application:

• HER-2+ Advanced Breast Cancer
• HER-3+ Metastatic Breast Cancer
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Hengrui Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pyrotinib market?

What factors are driving Pyrotinib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pyrotinib market opportunities vary by end market size?

How does Pyrotinib break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pyrotinib Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Pyrotinib by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Pyrotinib by Country/Region, 2020, 2024 & 2031
2.2 Pyrotinib Segment by Type
  2.2.1 160mg Tables
  2.2.2 80mg Tables
2.3 Pyrotinib Sales by Type
  2.3.1 Global Pyrotinib Sales Market Share by Type (2020-2025)
  2.3.2 Global Pyrotinib Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Pyrotinib Sale Price by Type (2020-2025)
2.4 Pyrotinib Segment by Application
  2.4.1 HER-2+ Advanced Breast Cancer
  2.4.2 HER-3+ Metastatic Breast Cancer
  2.4.3 Others
2.5 Pyrotinib Sales by Application
  2.5.1 Global Pyrotinib Sale Market Share by Application (2020-2025)
  2.5.2 Global Pyrotinib Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Pyrotinib Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Pyrotinib Breakdown Data by Company
  3.1.1 Global Pyrotinib Annual Sales by Company (2020-2025)
  3.1.2 Global Pyrotinib Sales Market Share by Company (2020-2025)
3.2 Global Pyrotinib Annual Revenue by Company (2020-2025)
  3.2.1 Global Pyrotinib Revenue by Company (2020-2025)
  3.2.2 Global Pyrotinib Revenue Market Share by Company (2020-2025)
3.3 Global Pyrotinib Sale Price by Company
3.4 Key Manufacturers Pyrotinib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Pyrotinib Product Location Distribution
  3.4.2 Players Pyrotinib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PYROTINIB BY GEOGRAPHIC REGION

4.1 World Historic Pyrotinib Market Size by Geographic Region (2020-2025)
  4.1.1 Global Pyrotinib Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Pyrotinib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pyrotinib Market Size by Country/Region (2020-2025)
  4.2.1 Global Pyrotinib Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Pyrotinib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pyrotinib Sales Growth
4.4 APAC Pyrotinib Sales Growth
4.5 Europe Pyrotinib Sales Growth
4.6 Middle East & Africa Pyrotinib Sales Growth

5 AMERICAS

5.1 Americas Pyrotinib Sales by Country
  5.1.1 Americas Pyrotinib Sales by Country (2020-2025)
  5.1.2 Americas Pyrotinib Revenue by Country (2020-2025)
5.2 Americas Pyrotinib Sales by Type (2020-2025)
5.3 Americas Pyrotinib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pyrotinib Sales by Region
  6.1.1 APAC Pyrotinib Sales by Region (2020-2025)
  6.1.2 APAC Pyrotinib Revenue by Region (2020-2025)
6.2 APAC Pyrotinib Sales by Type (2020-2025)
6.3 APAC Pyrotinib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Pyrotinib by Country
  7.1.1 Europe Pyrotinib Sales by Country (2020-2025)
  7.1.2 Europe Pyrotinib Revenue by Country (2020-2025)
7.2 Europe Pyrotinib Sales by Type (2020-2025)
7.3 Europe Pyrotinib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pyrotinib by Country
  8.1.1 Middle East & Africa Pyrotinib Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Pyrotinib Revenue by Country (2020-2025)
8.2 Middle East & Africa Pyrotinib Sales by Type (2020-2025)
8.3 Middle East & Africa Pyrotinib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pyrotinib
10.3 Manufacturing Process Analysis of Pyrotinib
10.4 Industry Chain Structure of Pyrotinib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Pyrotinib Distributors
11.3 Pyrotinib Customer

12 WORLD FORECAST REVIEW FOR PYROTINIB BY GEOGRAPHIC REGION

12.1 Global Pyrotinib Market Size Forecast by Region
  12.1.1 Global Pyrotinib Forecast by Region (2026-2031)
  12.1.2 Global Pyrotinib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pyrotinib Forecast by Type (2026-2031)
12.7 Global Pyrotinib Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Hengrui Pharmaceutical
  13.1.1 Hengrui Pharmaceutical Company Information
  13.1.2 Hengrui Pharmaceutical Pyrotinib Product Portfolios and Specifications
  13.1.3 Hengrui Pharmaceutical Pyrotinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Hengrui Pharmaceutical Main Business Overview
  13.1.5 Hengrui Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Pyrotinib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pyrotinib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 160mgTables
Table 4. Major Players of 80mgTables
Table 5. Global Pyrotinib Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Pyrotinib Sales Market Share by Type (2020-2025)
Table 7. Global Pyrotinib Revenue by Type (2020-2025) & ($ million)
Table 8. Global Pyrotinib Revenue Market Share by Type (2020-2025)
Table 9. Global Pyrotinib Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Pyrotinib Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Pyrotinib Sale Market Share by Application (2020-2025)
Table 12. Global Pyrotinib Revenue by Application (2020-2025) & ($ million)
Table 13. Global Pyrotinib Revenue Market Share by Application (2020-2025)
Table 14. Global Pyrotinib Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Pyrotinib Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Pyrotinib Sales Market Share by Company (2020-2025)
Table 17. Global Pyrotinib Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Pyrotinib Revenue Market Share by Company (2020-2025)
Table 19. Global Pyrotinib Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Pyrotinib Producing Area Distribution and Sales Area
Table 21. Players Pyrotinib Products Offered
Table 22. Pyrotinib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pyrotinib Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Pyrotinib Sales Market Share Geographic Region (2020-2025)
Table 27. Global Pyrotinib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Pyrotinib Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Pyrotinib Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Pyrotinib Sales Market Share by Country/Region (2020-2025)
Table 31. Global Pyrotinib Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Pyrotinib Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Pyrotinib Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Pyrotinib Sales Market Share by Country (2020-2025)
Table 35. Americas Pyrotinib Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Pyrotinib Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Pyrotinib Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Pyrotinib Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Pyrotinib Sales Market Share by Region (2020-2025)
Table 40. APAC Pyrotinib Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Pyrotinib Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Pyrotinib Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Pyrotinib Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Pyrotinib Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Pyrotinib Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Pyrotinib Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Pyrotinib Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Pyrotinib Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Pyrotinib Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Pyrotinib Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Pyrotinib
Table 52. Key Market Challenges & Risks of Pyrotinib
Table 53. Key Industry Trends of Pyrotinib
Table 54. Pyrotinib Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pyrotinib Distributors List
Table 57. Pyrotinib Customer List
Table 58. Global Pyrotinib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Pyrotinib Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Pyrotinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Pyrotinib Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Pyrotinib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Pyrotinib Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Pyrotinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Pyrotinib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Pyrotinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Pyrotinib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Pyrotinib Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Pyrotinib Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Pyrotinib Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Pyrotinib Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Hengrui Pharmaceutical Basic Information, Pyrotinib Manufacturing Base, Sales Area and Its Competitors
Table 73. Hengrui Pharmaceutical Pyrotinib Product Portfolios and Specifications
Table 74. Hengrui Pharmaceutical Pyrotinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Hengrui Pharmaceutical Main Business
Table 76. Hengrui Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Pyrotinib
Figure 2. Pyrotinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pyrotinib Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Pyrotinib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pyrotinib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pyrotinib Sales Market Share by Country/Region (2024)
Figure 10. Pyrotinib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 160mgTables
Figure 12. Product Picture of 80mgTables
Figure 13. Global Pyrotinib Sales Market Share by Type in 2025
Figure 14. Global Pyrotinib Revenue Market Share by Type (2020-2025)
Figure 15. Pyrotinib Consumed in HER-2+ Advanced Breast Cancer
Figure 16. Global Pyrotinib Market: HER-2+ Advanced Breast Cancer (2020-2025) & (K Pcs)
Figure 17. Pyrotinib Consumed in HER-3+ Metastatic Breast Cancer
Figure 18. Global Pyrotinib Market: HER-3+ Metastatic Breast Cancer (2020-2025) & (K Pcs)
Figure 19. Pyrotinib Consumed in Others
Figure 20. Global Pyrotinib Market: Others (2020-2025) & (K Pcs)
Figure 21. Global Pyrotinib Sale Market Share by Application (2024)
Figure 22. Global Pyrotinib Revenue Market Share by Application in 2025
Figure 23. Pyrotinib Sales by Company in 2025 (K Pcs)
Figure 24. Global Pyrotinib Sales Market Share by Company in 2025
Figure 25. Pyrotinib Revenue by Company in 2025 ($ millions)
Figure 26. Global Pyrotinib Revenue Market Share by Company in 2025
Figure 27. Global Pyrotinib Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Pyrotinib Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Pyrotinib Sales 2020-2025 (K Pcs)
Figure 30. Americas Pyrotinib Revenue 2020-2025 ($ millions)
Figure 31. APAC Pyrotinib Sales 2020-2025 (K Pcs)
Figure 32. APAC Pyrotinib Revenue 2020-2025 ($ millions)
Figure 33. Europe Pyrotinib Sales 2020-2025 (K Pcs)
Figure 34. Europe Pyrotinib Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Pyrotinib Sales 2020-2025 (K Pcs)
Figure 36. Middle East & Africa Pyrotinib Revenue 2020-2025 ($ millions)
Figure 37. Americas Pyrotinib Sales Market Share by Country in 2025
Figure 38. Americas Pyrotinib Revenue Market Share by Country (2020-2025)
Figure 39. Americas Pyrotinib Sales Market Share by Type (2020-2025)
Figure 40. Americas Pyrotinib Sales Market Share by Application (2020-2025)
Figure 41. United States Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Pyrotinib Sales Market Share by Region in 2025
Figure 46. APAC Pyrotinib Revenue Market Share by Region (2020-2025)
Figure 47. APAC Pyrotinib Sales Market Share by Type (2020-2025)
Figure 48. APAC Pyrotinib Sales Market Share by Application (2020-2025)
Figure 49. China Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 53. India Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Pyrotinib Sales Market Share by Country in 2025
Figure 57. Europe Pyrotinib Revenue Market Share by Country (2020-2025)
Figure 58. Europe Pyrotinib Sales Market Share by Type (2020-2025)
Figure 59. Europe Pyrotinib Sales Market Share by Application (2020-2025)
Figure 60. Germany Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 61. France Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Pyrotinib Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Pyrotinib Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Pyrotinib Sales Market Share by Application (2020-2025)
Figure 68. Egypt Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Pyrotinib Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Pyrotinib in 2025
Figure 74. Manufacturing Process Analysis of Pyrotinib
Figure 75. Industry Chain Structure of Pyrotinib
Figure 76. Channels of Distribution
Figure 77. Global Pyrotinib Sales Market Forecast by Region (2026-2031)
Figure 78. Global Pyrotinib Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Pyrotinib Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Pyrotinib Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Pyrotinib Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Pyrotinib Revenue Market Share Forecast by Application (2026-2031)